Chest, Vol 96, 1005-1011, Copyright © 1989 by American College of Chest Physicians

ARTICLES

Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma Cases

T Iizuka, K Isono, T Kakegawa and H Watanabe
National Ooji Hospital, Tokyo, Japan.

From January 1969 to December 1980, 8,948 patients with esophageal carcinoma were registered in Japan. Among these patients, 5,506 underwent resection. The ten-year survival rate was 12.3 percent for all registered patients and 18.7 percent for resected cases. Female patients had significantly better survival rates than male patients. Depth of invasion correlated better with ten-year survival than the superficial extent of the tumor. The TNM classification revised in 1987 was examined in relation to the survival, and it was found to have good prognostic value.

This article has been cited by other articles:

				M. Tachibana, S. Kinugasa, H. Yoshimura, D. K. Dhar, and N. Nagasue Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer Arch Surg, December 1, 2003; 138(12): 1383 - 1389. [Abstract] [Full Text] [PDF]

				S. Koyama and H. Tsujii Proton Beam Therapy with High-Dose Irradiation for Superficial and Advanced Esophageal Carcinomas Clin. Cancer Res., September 1, 2003; 9(10): 3571 - 3577. [Abstract] [Full Text] [PDF]

				H. Takeuchi, S. Ozawa, N. Ando, Y. Kitagawa, M. Ueda, and M. Kitajima Cell-Cycle Regulators and the Ki-67 Labeling Index Can Predict the Response to Chemoradiotherapy and the Survival of Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus Ann. Surg. Oncol., August 1, 2003; 10(7): 792 - 800. [Abstract] [Full Text] [PDF]

				K. Kagei, M. Hosokawa, H. Shirato, T. Kusumi, Y. Shimizu, A. Watanabe, and M. Ueda Efficacy of Intense Screening and Treatment for Synchronous Second Primary Cancers in Patients with Esophageal Cancer Jpn. J. Clin. Oncol., April 1, 2002; 32(4): 120 - 127. [Abstract] [Full Text] [PDF]

				D. J. Adelstein, T. W. Rice, L. A. Rybicki, M. A. Larto, J. Ciezki, J. Saxton, M. DeCamp, J. J. Vargo, J. A. Dumot, and G. Zuccaro Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy J. Clin. Oncol., May 10, 2000; 18(10): 2032 - 2039. [Abstract] [Full Text] [PDF]

				N. A. Christie, T. W. Rice, M. M. DeCamp, J. R. Goldblum, D. J. Adelstein, G. Zuccaro Jr, L. A. Rybicki, and E. H. Blackstone M1A/M1B ESOPHAGEAL CARCINOMA: CLINICAL RELEVANCE J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 900 - 907. [Abstract] [Full Text] [PDF]

				M. Shibakita, M. Tachibana, D. K. Dhar, T. Kotoh, S. Kinugasa, H. Kubota, R. Masunaga, and N. Nagasue Prognostic Significance of Fas and Fas Ligand Expressions in Human Esophageal Cancer Clin. Cancer Res., September 1, 1999; 5(9): 2464 - 2469. [Abstract] [Full Text] [PDF]

				M. Tachibana, S. Kinugasa, D. K. Dhar, H. Tabara, R. Masunaga, T. Kotoh, H. Kubota, and N. Nagasue Prognostic Factors in T1 and T2 Squamous Cell Carcinoma of the Thoracic Esophagus Arch Surg, January 1, 1999; 134(1): 50 - 54. [Abstract] [Full Text] [PDF]

				R. J. Korst, V. W. Rusch, E. Venkatraman, M. S. Bains, M. E. Burt, R. J. Downey, and R. J. Ginsberg Proposed Revision Of The Staging Classification For Esophageal Cancer J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 660 - 670. [Abstract] [Full Text]

				A. J. McLarty, C. Deschamps, V. F. Trastek, M. S. Allen, P. C. Pairolero, and W. S. Harmsen Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Ann. Thorac. Surg., June 1, 1997; 63(6): 1568 - 1571. [Abstract] [Full Text]